Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 6,200 shares at $14.18 ($88K) on 2019-10-15, disclosed to the SEC on 2019-10-16.
Open-market sale of $88k FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |